about
sameAs
Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress responseCardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series studyCharacterizing treatment pathways at scale using the OHDSI networkHospitalization for drug-induced hepatotoxicity: linking Y-codes with pharmaceutical claims data to identify implicated medicines.Impact on Drug Safety of Variation in Adherence: The Need for Routinely Reporting Measures of Dose Intensity in Medication Safety Studies Using Electronic Health Data.The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study.Association between use of multiple psychoactive medicines and hospitalization for falls: retrospective analysis of a large healthcare claim database.A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly.Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.Ranibizumab and risk of hospitalisation for ischaemic stroke and myocardial infarction in patients with age-related macular degeneration: a self-controlled case-series analysis.Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designsBridging evidence-practice gaps: improving use of medicines in elderly Australian veterans.Update of a prospective study of mortality and cancer incidence in the Australian petroleum industryPerioperative mortality after hemiarthroplasty related to fixation method.Comparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson Measures: a cross-sectional evaluation.Opioid use after total hip arthroplasty surgery is associated with revision surgery.Trends over 5 years in cardiovascular medicine use in Australian veterans with diabetesVariation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six CountriesUpdate of mortality and cancer incidence in the Australian petroleum industry cohort.Predictive performance of four frailty measures in an older Australian populationPotential risk factors for prolonged recovery following whiplash injuryPrescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries.Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners.Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study.Postoperative opioid use as an early indication of total hip arthroplasty failure.Heart failure after conventional metal-on-metal hip replacements.The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study.Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans.The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.Brief Report: Databases in the Asia-Pacific Region: The Potential for a Distributed Network Approach.Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies.Increase in Total Joint Arthroplasty Projected from 2014 to 2046 in Australia: A Conservative Local Model With International Implications.Use of SGLT2 inhibitors for diabetes and risk of infection: Analysis using general practice records from the NPS MedicineWise MedicineInsight program.Posttraumatic Stress Disorder, Antipsychotic Use and Risk of Dementia in Veterans.Understanding 30-day re-admission after hospitalisation of older patients for diabetes: identifying those at greatest risk.Patient-specific prescriber feedback can increase the rate of osteoporosis screening and treatment: results from two national interventions.Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change.Association between Ophthalmic Timolol and Hospitalisation for Bradycardia.Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?
P50
Q21262994-AFF3E9D4-E208-4153-AB17-F857DE64B851Q24658644-FC88AF59-CD81-4D42-B2E3-EB5156AD1184Q27320806-704BAE3D-A9BD-4FE0-B249-A536FDF642C0Q30892973-DA4DC8DC-F08D-47FB-8ABF-FE0AD1CACF7DQ30994474-B8BA84B0-4291-443C-A0F8-8FCC864E1C3EQ33673821-44B36B05-6675-4416-9F1A-D76401AD6511Q33829123-F937D6C7-0EE4-4F7D-B6E9-4F75EE905422Q33962657-2C22C7B3-FD03-4C85-94A2-6AAD106F061DQ34298335-B910D421-F6D9-4313-B5F6-A1C06F44DE48Q34567356-1B49AC78-707C-48EA-9F62-86CD94B4F1E4Q34783099-9CACC38B-FA3E-40CB-9013-4CA88277CFB5Q35065541-00337A6D-BA58-4329-B069-B64045D9F265Q35500255-9018CAC3-CF9D-4D53-9E62-1B3987281F87Q35606081-F30CB6DD-C6D7-47A3-89DF-596936764FC5Q35864928-3D7B819C-A60B-4D9C-B135-C88A80A262D1Q35953453-1601B361-F178-4B58-8BC7-6E85D1D64B19Q36024559-6D941067-A0FB-497B-ADF5-BDE0DB046A19Q36034337-75FA763D-B07C-41BA-A8A4-C2D119C5264DQ36166447-582F4264-6B28-4AAE-BF57-B3D623AD1141Q36208551-D43A3110-6243-40C1-B2A0-44E6404F3C57Q36333883-B1B7B08E-B3E5-4245-B58F-86F7599C09B8Q36402633-722AB519-B16A-438C-B872-BEC15220EB52Q36809894-41D1F694-ECC0-40E9-B038-58AF28A7E40CQ36861221-4D766E9C-6BF5-4D49-9529-F10815BAFFAAQ37077498-BFAD547D-3547-46A6-A22F-C06CCCCA2163Q37597154-AB78DC01-0D14-4090-A009-8DC5EF13F54AQ37609698-79B2C145-EC0E-4613-AD83-ED33411B20BFQ37812394-BA6F1DC7-C7C8-4797-92B5-8CFF9F9C2E74Q38105056-94B7617B-1F97-417E-9B70-3903B621E7CFQ38541569-088607F6-0F85-4224-A132-C369A450CBBBQ38683173-2B6DBC7D-C210-4285-A2D5-6433A60FC060Q38685782-FD579908-1772-4966-9888-90E3BBD32496Q38710922-F5041B27-CFF0-476F-91C7-7156646F2295Q38901341-C68139A5-1C74-4EEF-9A85-292F15C1CCEAQ38933120-3096DE11-5573-424D-9C84-45DB86AD3253Q38966388-DC1D175E-B256-4516-86FF-26450FFBE1EAQ39128482-0E5D8CC2-207A-46FB-8D3C-0FBFF2815CECQ39238736-F0CCEBC0-C067-4956-866C-02C35F065A7BQ39373841-0911304F-E1E7-4123-AB31-0A62A5161A56Q39495942-89ED1F3D-B340-49C9-BCB2-4DCD1FFBB075
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicole Pratt
@ast
Nicole Pratt
@en
Nicole Pratt
@es
Nicole Pratt
@nl
Nicole Pratt
@sl
type
label
Nicole Pratt
@ast
Nicole Pratt
@en
Nicole Pratt
@es
Nicole Pratt
@nl
Nicole Pratt
@sl
prefLabel
Nicole Pratt
@ast
Nicole Pratt
@en
Nicole Pratt
@es
Nicole Pratt
@nl
Nicole Pratt
@sl
P1053
A-1348-2011
P106
P1153
7005585291
P21
P31
P3829
P496
0000-0001-8730-8910